Half of people stop taking popular weight-loss drug within a year, study finds
Credit: Unsplash/CC0 Public Domain The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at ...
Credit: Unsplash/CC0 Public Domain The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at ...
Credit: Antioxidants (2025). DOI: 10.3390/antiox14091096 Scientists have identified a natural extract that could help boost the effectiveness of cancer drugs. ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
Cancer immunotherapy, which primes the body's immune system to fight off tumors, has historically focused on harnessing T cells' natural ...
Akeso, a Chinese biotech with a drug positioned to rival Merck’s megablockbuster Keytruda, has reported for the first time that ...
Jameela Jamil is weighing in on what makes her “uncomfortable” about Serena Williams’ admission that she is using a GLP-1 ...
As with most rare diseases, the market for hereditary angioedema drugs is small. It’s also relatively crowded, served by several ...
Cat hair, pests, bacteria, and equipment failures. These were among the concerns of a recent regulatory inspection of a key, ...
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Friday to treat an increasingly common liver disease, adding ...
Credit: Pixabay/CC0 Public Domain Drug treatment for people with newly diagnosed attention deficit hyperactivity disorder (ADHD) is associated with significantly ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.